At Drug Target Review, we believe your views are important and we want to hear your thoughts on cell and gene therapy.

As this class of biologics accelerate towards the clinic, we want to know what you believe is most promising about cell and gene therapies and where the challenges lie in translating them from the laboratory to patients.

By taking part, the data you have supplied will be used anonymously in a brand-new market report, alongside in-depth market research to further assess these trends, plus exclusive insight from a range of industry experts. The survey should take no longer than five minutes to complete.

If you wish to receive an exclusive copy of the report, please provide us with your details at the end of the survey.